Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1999 February; 79(3-4): 377–385.
PMCID: PMC2362451

Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells


We isolated six clones of weakly tumorigenic fibrosarcoma (QR) from the tumorigenic clone BMT-11 cl-9. The QR clones were unable to grow in normal C57BL/6 mice when injected s.c. (1 × 105 cells). However, they formed aggressive tumours upon co-implantation with a ‘foreign body’, i.e. a gelatin sponge, and the rate of tumour take ranged from 8% to 58% among QR clones. The enhanced tumorigenicity was due to host cell-mediated reaction to the gelatin sponge (inflammation). Immunoblot analysis and enzyme activity assay revealed a significant inverse correlation between the frequencies of tumour formation by QR clones and the levels of manganese superoxide dismutase (Mn-SOD, P<0.005) and glutathione peroxidase (GPχ, P<0.01) in the respective tumour clones. Electron spin resonance (ESR) revealed that superoxide-scavenging ability of cell lysates of the QR clone with high level of Mn-SOD was significantly higher than that with low level of the antioxidative enzyme in the presence of potassium cyanide, an inhibitor for copper–zinc superoxide dismutase (CuZn-SOD) (P<0.001). Minisatellite mutation (MSM) induced by the inflammatory cells in tumour cells were investigated by DNA fingerprint analysis after QR clones had been co-cultured with gelatin-sponge-reactive cells. The MSM rate was significantly higher in the subclones with low levels of Mn-SOD and GPχ (P<0.05) than in the subclones with high levels of both enzymes. The MSM of the subclones with low levels of both enzymes was inhibited in the presence of mannitol, a hydroxyl radical scavenger. The content of 8-hydroxydeoxyguanosine (8-OHdG) by which the cellular DNA damage caused by active oxygen species can be assessed was significantly low in the tumours arising from the QR clone with high levels of Mn-SOD and GPχ even if the clone had been co-implanted with gelatin sponge, compared with the arising tumour from the QR clone with low levels of those antioxidative enzymes (P<0.001). In contrast, CuZn-SOD and catalase levels in the six QR clones did not have any correlation with tumour progression parameters. These results suggest that tumour progression is accelerated by inflammation-induced active oxygen species particularly accompanied with declined levels of intracellular antioxidative enzymes in tumour cells. © 1999 Cancer Research Campaign

Keywords: tumour progression, inflammation, antioxidative enzymes, active oxygen species, minisatellite instability

Full Text

The Full Text of this article is available as a PDF (143K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Akporiaye ET, Kudalore MK. Implantation of a gelatin-sponge as a model for effector recruitment. Tumor growth inhibition by T-lymphocytes recovered from a site of tumor rejection. Cancer Immunol Immunother. 1989;29(3):199–204. [PubMed]
  • Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915–7922. [PubMed]
  • Aruoma OI, Halliwell B, Gajewski E, Dizdaroglu M. Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem J. 1991 Feb 1;273(Pt 3):601–604. [PubMed]
  • Ascher NL, Ferguson RM, Hoffman R, Simmons RL. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation. 1979 Apr;27(4):254–259. [PubMed]
  • Badwey JA, Karnovsky ML. Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem. 1980;49:695–726. [PubMed]
  • Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971 Nov;44(1):276–287. [PubMed]
  • BEERS RF, Jr, SIZER IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952 Mar;195(1):133–140. [PubMed]
  • Blackburn EH. Structure and function of telomeres. Nature. 1991 Apr 18;350(6319):569–573. [PubMed]
  • Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979 Jul;59(3):527–605. [PubMed]
  • Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994 Jul;35(7):950–954. [PMC free article] [PubMed]
  • Filmus J, Kerbel RS. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr Opin Oncol. 1993 Jan;5(1):123–129. [PubMed]
  • Foulds L. Multiple etiologic factors in neoplastic development. Cancer Res. 1965 Sep;25(8):1339–1347. [PubMed]
  • Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1987 Nov;1(5):358–364. [PubMed]
  • Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990 Aug 30;346(6287):866–868. [PubMed]
  • Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 1992 Nov 1;298(2):446–451. [PubMed]
  • Ishikawa M, Okada F, Hamada J, Hosokawa M, Kobayashi H. Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine. Int J Cancer. 1987 Mar 15;39(3):338–342. [PubMed]
  • Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 1984 Feb 24;12(4):2137–2145. [PMC free article] [PubMed]
  • Kasai H, Nishimura S, Kurokawa Y, Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis. 1987 Dec;8(12):1959–1961. [PubMed]
  • Kawaguchi T, Noji S, Uda T, Nakashima Y, Takeyasu A, Kawai Y, Takagi H, Tohyama M, Taniguchi N. A monoclonal antibody against COOH-terminal peptide of human liver manganese superoxide dismutase. J Biol Chem. 1989 Apr 5;264(10):5762–5767. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Ledwith BJ, Storer RD, Prahalada S, Manam S, Leander KR, van Zwieten MJ, Nichols WW, Bradley MO. DNA fingerprinting of 7,12-dimethylbenz[a]anthracene-induced and spontaneous CD-1 mouse liver tumors. Cancer Res. 1990 Sep 1;50(17):5245–5249. [PubMed]
  • Ledwith BJ, Joslyn DJ, Troilo P, Leander KR, Clair JH, Soper KA, Manam S, Prahalada S, van Zwieten MJ, Nichols WW. Induction of minisatellite DNA rearrangements by genotoxic carcinogens in mouse liver tumors. Carcinogenesis. 1995 May;16(5):1167–1172. [PubMed]
  • Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol. 1994 Oct;56(4):423–435. [PubMed]
  • Li JJ, Oberley LW, St Clair DK, Ridnour LA, Oberley TD. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene. 1995 May 18;10(10):1989–2000. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Matsumura Y, Tarin D. DNA fingerprinting survey of various human tumors and their metastases. Cancer Res. 1992 Apr 15;52(8):2174–2179. [PubMed]
  • Middleton MM, Campbell PA. Functions of purified mouse neutrophils isolated from gelatin sponges. J Leukoc Biol. 1989 Nov;46(5):461–466. [PubMed]
  • Nagayasu H, Hamada J, Nakata D, Shibata T, Kobayashi M, Hosokawa M, Takeichi N. Reversible and irreversible tumor progression of a weakly malignant rat mammary carcinoma cell line by in vitro exposure to epidermal growth factor. Int J Oncol. 1998 Jan;12(1):197–202. [PubMed]
  • Nakae D, Mizumoto Y, Kobayashi E, Noguchi O, Konishi Y. Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amounts of rat liver tissue. Cancer Lett. 1995 Nov 6;97(2):233–239. [PubMed]
  • Oberley TD, Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol. 1997 Apr;12(2):525–535. [PubMed]
  • Okada F, Hosokawa M, Hasegawa J, Ishikawa M, Chiba I, Nakamura Y, Kobayashi H. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2. Cancer Immunol Immunother. 1990;31(6):358–364. [PubMed]
  • Okada F, Hosokawa M, Hamada JI, Hasegawa J, Kato M, Mizutani M, Ren J, Takeichi N, Kobayashi H. Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). Br J Cancer. 1992 Oct;66(4):635–639. [PMC free article] [PubMed]
  • Okada F, Hosokawa M, Hamada J, Hasegawa J, Mizutani M, Takeichi N, Kobayashi H. Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plates. Jpn J Cancer Res. 1993 Dec;84(12):1230–1236. [PubMed]
  • Okada F, Hosokawa M, Hasegawa J, Kuramitsu Y, Nakai K, Yuan L, Lao H, Kobayashi H, Takeichi N. Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells. Br J Cancer. 1994 Aug;70(2):233–238. [PMC free article] [PubMed]
  • Pitot HC. Progression: the terminal stage in carcinogenesis. Jpn J Cancer Res. 1989 Jul;80(7):599–607. [PubMed]
  • Schraufstätter I, Hyslop PA, Jackson JH, Cochrane CG. Oxidant-induced DNA damage of target cells. J Clin Invest. 1988 Sep;82(3):1040–1050. [PMC free article] [PubMed]
  • Shacter E, Beecham EJ, Covey JM, Kohn KW, Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis. 1988 Dec;9(12):2297–2304. [PubMed]
  • Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature. 1991 Jan 31;349(6308):431–434. [PubMed]
  • Eccles SA, Court WJ, Box GA, Dean CJ, Melton RG, Springer CJ. Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. Cancer Res. 1994 Oct 1;54(19):5171–5177. [PubMed]
  • Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. [PubMed]
  • Suemizu H, Yoshimura S, Takeichi N, Moriuchi T. Decreased expression of liver glutathione peroxidase in Long-Evans cinnamon mutant rats predisposed to hepatitis and hepatoma. Hepatology. 1994 Mar;19(3):694–700. [PubMed]
  • Suzuki S, Takada T, Sugawara Y, Muto T, Kominami R. Quercetin induces recombinational mutations in cultured cells as detected by DNA fingerprinting. Jpn J Cancer Res. 1991 Oct;82(10):1061–1064. [PubMed]
  • Takada T, Suzuki S, Sugawara Y, Kominami R, Arakawa M, Niwa O, Yokoro K. Somatic mutation during metastasis of a mouse fibrosarcoma line detected by DNA fingerprint analysis. Jpn J Cancer Res. 1992 Feb;83(2):165–170. [PubMed]
  • Thein SL, Jeffreys AJ, Gooi HC, Cotter F, Flint J, O'Connor NT, Weatherall DJ, Wainscoat JS. Detection of somatic changes in human cancer DNA by DNA fingerprint analysis. Br J Cancer. 1987 Apr;55(4):353–356. [PMC free article] [PubMed]
  • Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood. 1990 Aug 15;76(4):655–663. [PubMed]
  • Willard HF. Centromeres of mammalian chromosomes. Trends Genet. 1990 Dec;6(12):410–416. [PubMed]
  • Yamashina K, Miller BE, Heppner GH. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line. Cancer Res. 1986 May;46(5):2396–2401. [PubMed]
  • Yoshimura S, Komatsu N, Watanabe K. Purification and immunohistochemical localization of rat liver glutathione peroxidase. Biochim Biophys Acta. 1980 Jan 24;621(1):130–137. [PubMed]
  • Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res. 1991 Oct 15;51(20):5621–5625. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK